TechnologyThe BioInnovation Institute as a catalyst for European life...

The BioInnovation Institute as a catalyst for European life science startup creation

-

- Advertisment -spot_imgspot_imgspot_imgspot_img

To the Editor — Although a few European countries have had success in creating life science startups1, the continent as a whole still lags behind the USA in terms of number of startup deals and of total investments2. To try and harness the untapped potential of European research, Denmark’s Novo Nordisk Foundation (NNF) has established the BioInnovation Institute (BII). The institute’s model relies on four pillars: first, knowledge within the BII team; second, access to a very large network of investors, industry experts and government experts; third, the availability of a company incubator with state-of-the-art laboratory facilities; and fourth, founder-friendly financing in the form of convertible loans to startups and of grants for academic company-creation projects. The combination of these four pillars not only supports accelerated translation of academic research into startups but also catapults these startups to financeable inflection points.

This is a preview of subscription content

Access options

Subscribe to Nature+

Get immediate online access to the entire Nature family of 50+ journals

Subscribe to Journal

Get full journal access for 1 year

$99.00

only $8.25 per issue

All prices are NET prices.

VAT will be added later in the checkout.

Tax calculation will be finalised during checkout.

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: The BII model.

References

  1. van Wilgenburg, B., van Wilgenburg, K., Paisner, K., van Deventer, S. & Rooswinkel, R. W. Mapping the European startup landscape. Nat. Biotechnol. 37, 345–349 (2019).

    Article 

    Google Scholar
     

  2. Senior, M. Europe’s biotech renaissance. Nat. Biotechnol. 38, 408–415 (2020).

    CAS 
    Article 

    Google Scholar
     

Download references

Acknowledgements

We would like to thank our colleagues Matthias Wulf, Johanna Roostalu, Giles Dudley and Jonathan Robinson for constructive comments to this paper. We acknowledge funding from the Novo Nordisk Foundation to the BioInnovation Institute (grant no. NNF21SA0074038).

Author information

Authors and Affiliations

  1. BioInnovation Institute, Copenhagen, Denmark

    Jens Nielsen, Markus J. Herrgård & Bobby Soni

Corresponding author

Correspondence to
Jens Nielsen.

Ethics declarations

Competing interests

The authors are part of the leadership of BII.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nielsen, J., Herrgård, M.J. & Soni, B. The BioInnovation Institute as a catalyst for European life science startup creation.
Nat Biotechnol (2022). https://doi.org/10.1038/s41587-022-01416-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-022-01416-w

Read More

Latest news

- Advertisement -spot_imgspot_imgspot_imgspot_img

Similarity of hepatocytes from liver and from stem cells improved

<div data-src="https://scx2.b-cdn.net/gfx/news/2022/similarity-of-hepatocy.jpg" data-sub-html="Credit: Patrick Nell et al, Journal of Hepatology (2022)....

Must read

Rivian, Lucid rush to help buyers with existing EV tax credit before it expires

Luxury electric vehicle startups Rivian Automotive and Lucid Motors...

Aston Martin DBR22 concept car bows at Pebble Beach

Aston Martin is rolling out a concept car this...

VW, Mahindra deepen EV component cooperation

FRANKFURT -- Volkswagen Group and Mahindra and Mahindra will...
- Advertisement -spot_imgspot_imgspot_img

You might also likeRELATED
Recommended to you